• Ganetespib (STA-9090): Applied Workflows in Cancer Research

  2026-06-26

  Ganetespib (STA-9090) offers precision Hsp90 inhibition for robust tumor growth studies, enabling high-confidence data in cell-based and in vivo models. This guide details advanced experimental workflows, troubleshooting strategies, and protocol parameters that leverage its unique triazolone scaffold—setting your cancer research apart.

• Tetrandrine Alkaloid: Integrating Calcium Channel Modulation

  2026-06-26

  Explore how Tetrandrine, a potent alkaloid, enables advanced ion channel modulation and assay innovation. This article uniquely examines Tetrandrine's mechanistic profile, practical protocol parameters, and cross-domain research value.

• ECL Western Blotting Substrate: Protocol and Workflow Guide

  2026-06-25

  ECL Western Blotting Substrate (SKU K2187) provides a nonradioactive, chemiluminescent HRP detection solution designed to deliver high signal intensity with a clear background in Western blot assays. It is optimal for protein detection by chemiluminescence in molecular and cancer biology workflows, but should not be used for fluorescent or radioisotopic detection.

• BRD4 Inhibition Enhances Erastin-Induced Ferroptosis via ROS

  2026-06-25

  This study demonstrates that BRD4 inhibitors, including I-BET-762, significantly sensitize diverse cancer cell lines to erastin-induced ferroptosis by promoting ROS accumulation and downregulating FSP1. These findings clarify the mechanistic basis for combining BET inhibition with ferroptosis inducers in cancer research, highlighting new avenues for targeting ferroptosis resistance.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-06-24

  Chen et al. (2025) provide an in-depth molecular epidemiology of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. The study reveals a predominance of plasmid-borne blaNDM-1, high rates of multidrug resistance, and efficient gene transfer, underscoring the urgency for improved surveillance and targeted resistance research.

• BOP Reagent: Precision Tools for Next-Generation Peptide Pro

  2026-06-23

  Explore how BOP reagent (benzotriazol-1-yloxy-tris(dimethylamino)phosphanium hexafluorophosphate) advances peptide bond formation and phenyl ester preparation, empowering innovative prodrug strategies. This article dives deeper into mechanistic insights and modern applications, connecting foundational chemistry to translational oncology breakthroughs.

• Annexin V: Precision Phosphatidylserine Binding for Apoptosi

  2026-06-23

  Annexin V, a gold-standard phosphatidylserine binding protein, transforms early apoptosis detection with reproducibility and workflow flexibility. This guide translates the latest research and real-world troubleshooting into actionable strategies for cell death research, cancer studies, and advanced assay development.

• RNA Clean and Concentrator Kit: Precision RNA Purification S

  2026-06-22

  The RNA Clean and Concentrator Kit delivers rapid, high-yield RNA purification via a spin column format. Its protocol enables removal of enzymatic contaminants, supporting research from in vitro transcription cleanup to disease modeling. This article details the kit’s mechanism, evidence base, and boundaries for advanced molecular workflows.

• Spermine: Endogenous Polyamine for Ion Channel Modulation

  2026-06-22

  Spermine is an endogenous polyamine essential for eukaryotic cell growth and protein synthesis. It functions as a potent physiological blocker of inward rectifier potassium (K+) channels, directly affecting ion channel regulation and cellular metabolism research. This article details its molecular mechanism, solubility, and best practices for experimental use, citing primary literature and product specifications.

• D-N-Acetylgalactosamine: Technical Use in Brain Glycoprotein

  2026-06-21

  D-N-Acetylgalactosamine is an essential metabolite for dissecting glycoprotein structure and function, particularly in brain tissue models. It is optimized for workflows requiring high purity and water solubility, but should not be used in protocols needing ethanol solubility or long-term solution storage.

• Cyanidin Chloride: Advanced Antioxidant in Cellular Stress M

  2026-06-20

  Cyanidin Chloride delivers robust, reproducible antioxidant performance in cell-based oxidative stress and inflammatory skin barrier models. Its high purity and validated efficacy enable researchers to dissect cell protection mechanisms and inflammatory pathways with confidence—especially in psoriasis and neurodegenerative disease models.

• ATRA Restores PARP Inhibitor Sensitivity in Cisplatin-Treate

  2026-06-19

  This study demonstrates that all-trans retinoic acid (ATRA) reverses PARP inhibitor resistance in epithelial ovarian cancer (EOC) cells following cisplatin exposure. By elucidating the molecular basis of this sensitization, the research suggests a promising therapeutic approach for overcoming resistance in both BRCA-mutant and wild-type EOC.

• FCCP in Mitochondrial Biology: Protocols, Pitfalls, and Inno

  2026-06-19

  FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) is a gold-standard mitochondrial uncoupler, indispensable for dissecting oxidative phosphorylation and hypoxia signaling. This guide delivers actionable protocols, troubleshooting tips, and insights on leveraging FCCP for cutting-edge metabolic and cancer research, with a spotlight on recent innovations in autophagy screening.

• Cabazitaxel (XRP6258): Technical Use in Resistant Tumor Mode

  2026-06-18

  Cabazitaxel (XRP6258) is a semi-synthetic taxane optimized for research applications involving taxane-resistant and P-glycoprotein-expressing tumor models. Best suited for DMSO- or ethanol-based in vitro and in vivo systems, it should not be used in water-based assays or for long-term storage of working solutions.

• AZD8055: Technical Guidance for mTOR Pathway Inhibition

  2026-06-18

  AZD8055 is a potent, selective mTOR inhibitor designed for precise inhibition of both mTORC1 and mTORC2, enabling detailed interrogation of PI3K/Akt/mTOR signaling in preclinical cancer and metabolic research models. It is not recommended for studies seeking clinical efficacy endpoints due to limited translation in late-phase trials. Researchers can use AZD8055 to dissect mTOR signaling mechanisms, but should be mindful of its solubility and storage requirements.

446 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page